BridgeMD
New treatment option for Echinococcosis, Hepatic
Official title Biliary Fistulas in Surgery of Liver Echinococcosis
ClinicalTrials.gov ID: NCT06612229
What this study is testing
- What it's testing
- The objective of the study is to improving the results of surgical treatment of liver echinococcosis complicated by biliary fistula by optimizing diagnostic approaches to early verification of this complication and improving the tactical and technical aspects of its elimination.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age under 18 years;
- Informed consent for inclusion in the study;
- The presence of liver echinococcosis, for which conservative surgical treatment will be performed;
- The presence of the entire spectrum of necessary preoperative diagnostic measures;
- A full description of all stages of surgical intervention, indicating the type of intervention (open or laparoscopic surgery, location and size of...
You likely can't join if
- Age under 18 years;
- Refusal to participate in the study;
- Extrahepatic echinococcosis without liver damage;
- Absence of the full range of preoperative diagnostic data;
- Difficulties with objective analysis of the features of the performed surgical treatment;
- Incomplete data on monitoring the postoperative hospital and remote (up to 3 months) period;
See the full eligibility criteria
- Age under 18 years;
- Informed consent for inclusion in the study;
- The presence of liver echinococcosis, for which conservative surgical treatment will be performed;
- The presence of the entire spectrum of necessary preoperative diagnostic measures;
- A full description of all stages of surgical intervention, indicating the type of intervention (open or laparoscopic surgery, location and size of the echinococcal cyst in the liver, type of antiparasitic treatment...
- Availability of objective data on the characteristics of the postoperative course, including dynamic indicators of the patient\'s condition, temperature, amount and nature of discharge through the drainage, the time of...
- Absence of concomitant pathology that may affect the outcome of the surgery.
- Age under 18 years;
- Refusal to participate in the study;
- Extrahepatic echinococcosis without liver damage;
- Absence of the full range of preoperative diagnostic data;
- Difficulties with objective analysis of the features of the performed surgical treatment;
- Incomplete data on monitoring the postoperative hospital and remote (up to 3 months) period;
- The presence of concomitant pathology that may affect the outcome of the operation.
The study team makes the final eligibility decision.
Where it's taking place
- Tashkent, Uzbekistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tashkent, Uzbekistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.